Commercially available benzo[e]perimidine-4-carboxylic acid 3a displays the greatest similarity in anti-cancer activity to DPIQ, with a PCC of 0.87, and a moderate to strong PCC of 0.64 to NQO1 expression across the NCI-60 cell line panel (Figure 1). This evidence concerns the gene NQO1 and cancer.